Dr. Novy concurred. "For people who are at risk, we see them more frequently. We involve their families in the treatment. We encourage the use of a pill box and pill count. We also monitor with random urine screens," she said, adding that M.D. Anderson is also starting to use an opioid compliance checklist similar to the COMM (Current Opioid Misuse Measure) that was developed by Robert N. Jamison, Ph.D., at Brigham and Women’s Hospital in Boston (Pain 2007;130:144-56).
Dr. Passik reported that he has received honoraria from Cephalon Inc., King Pharmaceuticals Inc. (now part of Pfizer Inc.), Pricara (a division of Ortho-McNeil-Janssen Pharmaceuticals Inc.), and Purdue Pharma LP. Dr. Koyyalagunta and Dr. Novy both reported that they have no relevant financial relationships.